Vlad Coric is the founder of Biohaven Pharmaceutical. Backed by Sixth Street, Pfizer. Based in New York, NY.
Vlad Coric, M.D., is the Chairman and Chief Executive Officer of Biohaven Pharmaceutical, a biopharmaceutical company focused on neurological and neuropsychiatric diseases. He led Biohaven's acquisition by Pfizer in May 2022 for approximately $13 billion. Under his leadership, Biohaven launched Nurtec ODT against established migraine treatments.
Full founder directory · Investor directory · Company funding database · Fundraising library